Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Raw Materials (2016 - 2025)

Utah Medical Products has reported Raw Materials over the past 15 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Raw Materials at $5.1 million for Q4 2025, down 7.29% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (down 7.29% YoY), and the annual figure for FY2025 was $5.1 million, down 7.29%.
  • Raw Materials for Q4 2025 was $5.1 million at Utah Medical Products, down from $5.5 million in the prior quarter.
  • Over the last five years, Raw Materials for UTMD hit a ceiling of $6.5 million in Q1 2023 and a floor of $3.4 million in Q3 2021.
  • Median Raw Materials over the past 5 years was $5.5 million (2024), compared with a mean of $5.2 million.
  • Biggest five-year swings in Raw Materials: fell 15.7% in 2021 and later soared 61.25% in 2023.
  • Utah Medical Products' Raw Materials stood at $3.7 million in 2021, then surged by 53.49% to $5.7 million in 2022, then rose by 11.69% to $6.4 million in 2023, then fell by 14.22% to $5.5 million in 2024, then decreased by 7.29% to $5.1 million in 2025.
  • The last three reported values for Raw Materials were $5.1 million (Q4 2025), $5.5 million (Q4 2024), and $6.3 million (Q3 2024) per Business Quant data.